Healthcare -
Biotechnology - NASDAQ - NL
$ 15.6
-1.89 %
$ 843 M
Market Cap
-5.71
P/E
Price Target
Average
134.43%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
25.99%
Net Income
Estimate
50.90%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Pharvaris N.V.
Wall Street analysts predict an average 1-year price target for PHVS of $36.6 , with forecasts ranging from
a
low of
$22 to a high of $50 .
PHVS Lowest Price Target
Wall Street Target
22 USD
41.03%
PHVS Average Price Target
Wall Street Target
36.6 USD
134.43%
PHVS Highest Price Target
Wall Street Target
50 USD
220.51%
REVENUE FORECAST
Revenue Forecast Chart PHVS
EBIT FORECAST
EBIT Forecast Chart PHVS
NET INCOME FORECAST
Net Income Chart PHVS